Anping Xu
Impact in
- Nephrology top 1%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
- Nephrology 12
- Chronic Kidney Disease and Diabetes 7
- Acute Kidney Injury Research 5
- Immunology 11
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Co-authors
- Ying Tang (15 shared papers)Junzhe Chen (14 shared papers)Hui Y. Lan (7 shared papers)Min Feng (8 shared papers)Patrick Ming‐Kuen Tang (3 shared papers)Erik Fung (2 shared papers)Xiao‐Ru Huang (3 shared papers)Mingsheng Zhu (2 shared papers)
- Journals
- Clinical Rheumatology (5 papers)BMC Nephrology (5 papers)Clinical Science (3 papers)Molecular Therapy (3 papers)Clinical Nephrology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Anping Xu
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Nephrology 389
- Rheumatology 141
- Immunology 165
- Critical Care and Intensive Care Medicine 35
- Cancer Research 110
Countries citing papers authored by Anping Xu
This map shows the geographic impact of Anping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anping Xu more than expected).
Fields of papers citing papers by Anping Xu
This network shows the impact of papers produced by Anping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anping Xu. The network helps show where Anping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 222 | |
| 2 | 2017 | 130 | |
| 3 | 2017 | 102 | |
| 4 | 2016 | 71 | |
| 5 | 2019 | 68 | |
| 6 | 2022 | 65 | |
| 7 | 2016 | 60 | |
| 8 | 2013 | 59 | |
| 9 | 2020 | 43 | |
| 10 | 2017 | 42 | |
| 11 | 2016 | 42 | |
| 12 | 2020 | 39 | |
| 13 | 2021 | 38 | |
| 14 | 2018 | 36 | |
| 15 | 2020 | 36 | |
| 16 | 2013 | 30 | |
| 17 | 2020 | 29 | |
| 18 | 2019 | 28 | |
| 19 | 2014 | 28 | |
| 20 | 2007 | 28 |
About Anping Xu
Anping Xu is a scholar working on Nephrology, Immunology, Rheumatology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (7 papers), Immune Cell Function and Interaction (5 papers), Acute Kidney Injury Research (5 papers), T-cell and B-cell Immunology (4 papers), Renal and related cancers (4 papers), Renal cell carcinoma treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Bone and Dental Protein Studies (2 papers). The work is most often cited by research in Nephrology (389 citations), Rheumatology (141 citations), Immunology (165 citations), Critical Care and Intensive Care Medicine (35 citations) and Cancer Research (110 citations). Anping Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ying Tang, Junzhe Chen, Hui Y. Lan, Min Feng, Patrick Ming‐Kuen Tang, Erik Fung, Xiao‐Ru Huang, Mingsheng Zhu, Gang Xu and Bi‐Cheng Liu. Their work appears in journals such as Clinical Rheumatology, BMC Nephrology, Clinical Science, Molecular Therapy and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.